CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
Xenon Photocoagulation +2 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000160
NCT00000160Phase 3Completed
CompareCT.gov

Diabetic Retinopathy Study (DRS)

National Eye Institute (NEI)·interventional·Posted Sep 24, 1999·Updated Jun 2, 2006

In Brief

A Phase 3 clinical trial evaluating Xenon Photocoagulation, Argon Photocoagulation, and 1 other intervention for Diabetic Retinopathy and Blindness. Completed.

Detailed Summary

To determine whether photocoagulation helps prevent severe visual loss from proliferative diabetic retinopathy. To determine whether a difference exists in the efficacy and safety of argon versus xenon photocoagulation for proliferative diabetic retinopathy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Retinopathy, Blindness
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
1971197219731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
First PostedSep 24, 1999
Enrollment StartJan 1, 1972
TodayJul 2, 2026
Posted 26.8 years ago

Interventions

Xenon Photocoagulationprocedure

Argon Photocoagulationprocedure

Photocoagulationprocedure